Product

Company

Clareo Health | Phosphate in Blood Pressure Regulation

NCT02822131·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Zurich

Age

20–45

Sex

MALE

Healthy volunteers

Accepted

\- Kidney disease (defined by eGFR \< 90 ml/min or microalbuminuria (\> 30mg/d))
Diabetes mellitus
Hypertension (RR \> 140/85 mmHg)
Hypotension (RR \< 90/60 mmHg)
any regular medication
non-Western type diet e.g. vegetarian, vegan etc.
History of kidney stones
Allergy to sulphonamides or penicillins
Hereditary fructose intolerance
known hypersensitivity or allergy to class of drugs used in this study
Glaucoma
Vitamin D deficiency (\< 20 ng/ml)
Hyper- or Hypoparathyroidism
Hypo- or hyperaldosteronism
Participation in any other study

The record

StatusCompleted

PhaseNo phase

Taking part10

StartedJan 2016

UpdatedJul 4, 2016

Conditions

Where1